Inactivation of severe acute respiratory syndrome coronavirus 2 in plasma and platelet products using a riboflavin and ultraviolet light-based photochemical treatment.

MLA

Keil, Shawn D., et al. “Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2 in Plasma and Platelet Products Using a Riboflavin and Ultraviolet Light-Based Photochemical Treatment.” Vox Sanguinis, vol. 115, no. 6, Aug. 2020, pp. 495–501. EBSCOhost, https://doi.org/10.1111/vox.12937.

APA

Keil, S. D., Ragan, I., Yonemura, S., Hartson, L., Dart, N. K., & Bowen, R. (2020). Inactivation of severe acute respiratory syndrome coronavirus 2 in plasma and platelet products using a riboflavin and ultraviolet light-based photochemical treatment. Vox Sanguinis, 115(6), 495–501. https://doi.org/10.1111/vox.12937

Chicago

Keil, Shawn D, Izabela Ragan, Susan Yonemura, Lindsay Hartson, Nicole K Dart, and Richard Bowen. 2020. “Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2 in Plasma and Platelet Products Using a Riboflavin and Ultraviolet Light-Based Photochemical Treatment.” Vox Sanguinis 115 (6): 495–501. doi:10.1111/vox.12937.